Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects

Sci Rep. 2016 Sep 19:6:33377. doi: 10.1038/srep33377.

Abstract

Some mutations of the LRRK2 gene underlie autosomal dominant form of Parkinson's disease (PD). The G2019S is a common mutation that accounts for about 2% of PD cases. To understand the pathophysiology of this mutation and its possible developmental implications, we developed an in vitro assay to model PD with human induced pluripotent stem cells (hiPSCs) reprogrammed from skin fibroblasts of PD patients suffering from the LRKK2 G2019S mutation. We differentiated the hiPSCs into neural stem cells (NSCs) and further into dopaminergic neurons. Here we show that NSCs bearing the mutation tend to differentiate less efficiently into dopaminergic neurons and that the latter exhibit significant branching defects as compared to their controls.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Dopaminergic Neurons / cytology*
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / enzymology*
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / genetics*
  • Mesencephalon / cytology
  • Mice
  • Mutation / genetics*
  • Neural Stem Cells / cytology
  • Neurites / metabolism*
  • Parkinson Disease / genetics
  • Phenotype

Substances

  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2